Skip to content

BIOETHICS, LTD.: 10-Q filed 2014-11-12

What BIOETHICS, LTD. reported in its quarterly report filed 2014-11-12 (fiscal Q3 2014): 25 published measures, 64 facts as tagged in accession 0001078782-14-001976.

This filing

Form
10-Q (quarterly report)
Filed
2014-11-12
Fiscal period
fiscal Q3 2014
Accession
0001078782-14-001976 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIOETHICS, LTD. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-30438USD
At 2013-12-31359USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-09-301,809USD
At 2013-12-3195,672USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-301,371USD
At 2013-12-3195,313USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-3058USD
At 2013-12-31359USD
At 2013-09-30529USD
At 2012-12-314,505USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-30995USD92
2014-01-01 to 2014-09-3016,195USD273
1990-07-26 to 2014-09-30215,284USD8833
2013-07-01 to 2013-09-305,758USD92
2013-01-01 to 2013-09-3017,351USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-09-3016,613USD273
1990-07-26 to 2014-09-30200,030USD8833
2013-01-01 to 2013-09-3013,976USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-07-01 to 2014-09-300USD92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-09-30175USD273
1990-07-26 to 2014-09-30200,088USD8833
2013-01-01 to 2013-09-3010,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-09-300USD273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-07-01 to 2014-09-300USD/shares92
2014-01-01 to 2014-09-300USD/shares273
2013-07-01 to 2013-09-300USD/shares92
2013-01-01 to 2013-09-300USD/shares273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-09-30438USD
At 2013-12-31359USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-09-302,123USD273
1990-07-26 to 2014-09-3014,000USD8833
2013-07-01 to 2013-09-301,210USD92
2013-01-01 to 2013-09-303,376USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-09-301,809USD
At 2013-12-3195,672USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-09-301,634USD
At 2013-12-313,795USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-3011,000,000shares
At 2013-12-3111,000,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-09-3097,913USD
At 2013-12-3192,776USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-30995USD92
2014-01-01 to 2014-09-3016,195USD273
1990-07-26 to 2014-09-30215,284USD8833
2013-07-01 to 2013-09-305,758USD92
2013-01-01 to 2013-09-3017,351USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2014-01-01 to 2014-09-3016,195USD273
1990-07-26 to 2014-09-30215,284USD8833
2013-01-01 to 2013-09-3017,351USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-30995USD92
2014-01-01 to 2014-09-3016,195USD273
2013-07-01 to 2013-09-305,758USD92
2013-01-01 to 2013-09-3017,351USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-30995USD92
2014-01-01 to 2014-09-3014,072USD273
1990-07-26 to 2014-09-30201,284USD8833
2013-07-01 to 2013-09-304,548USD92
2013-01-01 to 2013-09-3013,975USD273

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2014-07-01 to 2014-09-300USD92

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2014-07-01 to 2014-09-300USD92

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2014-01-01 to 2014-09-300USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
1990-07-26 to 2014-09-3041,000USD8833

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-302,161USD273
1990-07-26 to 2014-09-301,634USD8833

Inspect the source

Entity
BIOETHICS, LTD. / CIK 0000894560
Captured
2026-09-21T17:17:38.882Z
SEC response SHA-256
e63ab37f38651b83b536a7eed9a4e97024dac8ca5b82db7de0e58af08bd993b2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000894560.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))